FB0 · (2R,3S,4S)-5-({[(acetylcarbamoyl)amino]methyl}[(3S,4R)-6-amino-3,4-dimethylhexyl]amino)-2,3,4-trihydroxypentyl [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name)

Binding sites

FB0 in 2 structures; the first of them:

• 3NN6 · Crystal structure of inhibitor-bound in active centre 6-hydroxy-L-nicotine oxidase from… · FB0 X434 · binds VAL7, GLY8, GLY9, GLY10, PHE11, SER12, LEU30, GLU31 and 32 more
• 3NN6 · Crystal structure of inhibitor-bound in active centre 6-hydroxy-L- nicotine oxidase from… · FB0 X434 · binds VAL7, GLY8, GLY9, GLY10, PHE11, SER12, LEU30, GLU31 and 32 more

Residues it binds most

GLY 2, ALA 2, ILE 2, PHE 2, THR 2, VAL 2, LEU 2, PRO 2, SER 2, TRP 2 (residue and the binding sites it lines).

Found with

• GP7 · (1R)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(pentadecanoyloxy)methyl]ethyl (12E)-hexadeca-9,12-dienoate
• HNK · 5-[(2R)-1-methylpyrrolidin-2-yl]pyridin-2-ol